[1]
“DETERMINATION OF ATORVASTATINE IN PHARMACEUTICAL FORMULATIONS BY REVERSE PHASE-HIGH PERFORMANCE LIQUID CHROMATOGRAPHY”, Int J of Adv in Phar Ana, vol. 2, no. 2, pp. 47–52, Jul. 2012, doi: 10.7439/ijapa.v2i2.19.